April 29 - Breakingviews columnists discuss the U.S. drug giant’s hankering for AstraZeneca and whether more so-called inversion deals will follow suit.
01:14
01:55
01:25
01:09
02:23
02:44
00:45
02:24
01:58
01:04
01:03
01:56
00:32
01:12
01:04
01:06
00:49
03:01
02:49
00:53
01:09
02:23
02:25
01:14
00:56
00:57
01:19
01:10
02:25
01:13
00:56
01:13
00:20
01:19
01:15
01:03
01:07
01:09
01:13
02:03
01:14
02:44
02:23
01:04
01:03
00:32
02:25
01:06
02:00
01:14
03:20
00:57
01:36
01:00
01:27
01:05
01:07
01:02
01:39
01:49
01:00
01:27
00:50
02:19
04:48
01:22
01:12
01:02
01:00
01:43
01:14
00:51
02:15
04:16
00:58
01:20
01:33
01:14
01:42
01:19
00:49
00:53
02:42
01:41
01:05
01:05
01:42
02:21
01:07
00:58
01:15
00:58
02:08
00:47
01:22
01:13
01:18
01:10
01:59
01:13
02:00
01:04
01:19
00:47
01:26
01:13
01:22
01:22
01:15
01:20
01:33
01:28
01:48
02:33
01:28
03:40
01:05
01:15
01:28
01:24